95 results
Page 3 of 5
10-KT
b3a7hktbdyt9rmj43tq
31 Mar 21
Annual report (with FYE transition)
4:33pm
424B5
15odx0n6
18 Dec 20
Prospectus supplement for primary offering
1:26pm
8-K
mx1p6
8 Dec 20
Departure of Directors or Certain Officers
9:30am
424B5
hu8u5tz1xj93yr
2 Oct 20
Prospectus supplement for primary offering
4:24pm
424B5
meokjbj4ihn6d
4 Aug 20
Prospectus supplement for primary offering
6:16am
8-K
ug7syrbqjbom9k9o ssq
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
424B5
eaeanu6eylkq9
10 Jul 20
Prospectus supplement for primary offering
2:35pm
8-K
2pcl4k3yh z2u
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-10.18
0kyctecqvc4d tryq
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.17
n8komqmt5 3y
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.6
xz2kdzv
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-99.1
oca848h5xoh
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
p7odvqgu12nxh9ad mr
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.19
sqmjuc
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
424B3
0e00064hw6f aek
9 Apr 20
Prospectus supplement
9:30am